Bullous Pemphigoid and Dipeptidyl Peptidase-4 Inhibitors in Patients With Diabetes

This case-control study examines the association between the use of dipeptidyl peptidase 4 inhibitors and the risk of developing bullous pemphigoid in patients with diabetes.

https://jamanetwork.com/journals/jamadermatology/fullarticle/2719752

Source: JAMA Dermatology - January 9, 2019 Category: Dermatology Source Type: research